Brooklyn, NY, United States of America

Ilya Ruvimovich Kleyn

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ilya Ruvimovich Kleyn. Retrieved from https://idiyas.com/inventor/ilya-ruvimovich-kleyn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ilya Ruvimovich Kleyn: Innovator in Pharmaceutical Composition

Introduction

Ilya Ruvimovich Kleyn is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of medicine and pharmacy, particularly in the development of pharmaceutical compositions aimed at treating severe infectious diseases.

Latest Patents

Kleyn holds a patent for a polymyxin-based pharmaceutical composition designed for treating infectious diseases. This invention focuses on creating new pharmaceutical compositions that utilize polymyxin while minimizing nephrotoxic properties in therapeutic doses. The technical result of this innovation is the development of new combined dosage forms based on the antibiotic polymyxin, which exhibit low nephrotoxicity and high activity.

Career Highlights

Throughout his career, Kleyn has demonstrated a commitment to advancing medical science through innovative solutions. His work has the potential to significantly impact the treatment of severe infectious diseases, providing safer options for patients.

Collaborations

Kleyn has collaborated with notable colleagues, including Boris Farber and Artur Viktorovich Martynov, to further enhance his research and development efforts.

Conclusion

Ilya Ruvimovich Kleyn's contributions to pharmaceutical innovation highlight the importance of developing effective and safe treatments for infectious diseases. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…